Abstract. Many cancer-associated genes and pathways remain to be identified in order to clarify the molecular mechanisms underlying cancer progression. In this area, genome-wide lossof-function screens appear to be powerful biological tools, allowing the accumulation of large amounts of data. However, this approach currently lacks analytical tools to exploit the data with maximum efficiency, for which systems biology methods analyzing complex cellular networks may be extremely helpful. In this article we report such a systems biology strategy based on the construction of a Network for a biological process and specific for a given cell system (cell type). The networks are created from genome-wide loss-of-function screen datasets. We also propose tools to analyze network properties. As one of the tools, we suggest a mathematical model for discrimination between two distinct cell processes that may be affected by knocking down the activity of a gene, i. e., a decreased cell number may be caused by arrested cell proliferation or enhanced cell death. Next we show how this discrimination between the two cell processes helps to construct two corresponding subnetworks. Finally, we demonstrate an application of the proposed strategy to the identification and characterization of putative novel genes and pathways significant for the control of lung cancer cell growth, based on the results of a genome-wide proliferation/viability loss-of-function screen of human lung adenocarcinoma cells.
Introduction
Genome-wide loss-of-function (LOF) screens are powerful experimental techniques using RNA interference (RNAi) to obtain a comprehensive view of gene function in a given biological system. In these approaches, the genes from the whole genome are individually and systematically knocked down in a cell-based assay, and the resulting phenotypical modifications are quantified with aid of a relevant reporter. Usually this knockdown is performed by application of synthetic siRNAs (short interfering RNAs), which are short non-coding RNAs, each specifically designed for the knockdown of a given gene in the given type of genome (e.g. human, mice, fly, etc.). Genome-wide LOF screens are currently widely exploited biological tools, which generate a huge amount of data, but the analytical tools applied for processing these data and arriving at conclusions are generally not commensurate with the biological capability of this strong and expensive method. In practice, the results of such screens are either finally narrowed down to the discovery of 1-2 specific genes only, or, alternatively, undergo too-general systems biology analysis with conclusions barely (or not at all) meaningful with respect to real biological needs [5] - [14] . Here, we try to find a way between these Scylla and Charybdis, and to propose a powerful analytical tool, based on the concept of Specific Network, meaning a Network corresponding to a certain process and specific for a given cell system (e.g., given cell line, given cancer type, etc.). We suggest rules for construction of such a network based on datasets of genome-wide LOF screens performed in such a system, and provide tools for analysis of its specificity (non-randomness). The analysis of such a Specific Network helps to identify a set of genes and pathways in the given biological system that is significant for the given process under investigation (e.g. proliferation, differentiation, etc.).
It is very important to point out that network analysis, first of all, helps to ferret out those genes which are in fact very important for the process in the given system, but which were not identified in the screen due to technical/experimental reasons. Inclusion of additional genes-connectors to the genes found in the screen for creating a Specific Network, and next analysis of their characteristics in the corresponding network, helps to prove the importance of such genes using the "guilty by association" principle, despite the fact that these genes were not justified by the initial LOF screen.
Next we show an application of proposed systems biology approaches for the identification of novel genes and pathways potentially associated with lung cancer, by analysis of the Specific Network, based on the results of a genome-wide LOF proliferation/viability screen of human lung adenocarcinoma cells (cell line A549). The A549 cell line is a human lung adenocarcinoma cell line, which belongs to Non-Small-Cell Lung cancers (NSCLC) and bears the K-Ras oncogene. K-Ras is a G-protein acting directly downstream of the epidermal growth factor receptor (EGFR), and an essential component of the EGFR pathway, which is one of the major signaling pathways deregulated in lung cancer [20] . Indeed, K-Ras mutations are found in 20-40% of lung adenocarcinomas [21] . An important feature of the A549 cell line is that it expresses normal (wild type) tumor suppressor protein p53. Non-small cell lung cancers, and particularly the NSCLC adenocrcinoma subtype, are one of the main causes of human lethality [15, 16] , and the molecular mechanisms underlying its progression are still poorly understood. The therapies targeting well known pathways, such as the EGFR pathway [1, 2, 3, 17] , were shown to be effective for only a small fraction of NSCLC tumors. A very few reports show a role for specific genes, such as EML4-ALK [4] or CRK [18] , in lung adenocarcinoma progression, and they do not clarify the corresponding pathways.
A genome-wide RNAi-based LOF screen performed in our lab on the human lung adenocarcinoma A549 cell line resulted in the discovery of 203 genes negatively regulating cell proliferation, with or without associated effects on cell viability (assessed by a metabolic assay and a cytotoxicity reporter assay, respectively). In this article, we report the construction of A549 Specific Network using the results of this genome-wide RNAi screen, and suggest tools for its analysis.
The systems biology analysis of this A549 Specific Network revealed around 30 genes as being significant ones for human lung adenocarcinoma cell growth, i.e., influencing cell proliferation activity, growth, or viability. Discrimination between participation of these genes in the processes of proliferation or the maintenance of cell survival was arrived at using mathematical modeling of these processes. This involved retrieving the corresponding proliferation and cell survival subnetworks from the A549 Specific Network, thereby elucidating several pathways and modules in this system.
Results
2.1. Biological Background -hit genes found in genome-wide loss-of-function screen of A549 cells siRNAs (short interfering RNAs) are short non-coding RNAs that can induce sequence-specific gene knockdown via a silencing complex. In the course of a genome-wide LOF screen, a library containing siRNAs targeting each gene from the genome of interest is assembled, and next applied as separate samples to the cells growing in culture. This allows evaluation of the effect on the given biological process of knocking down each individual gene in the given cells, through quantification of a phenotypical readout corresponding to the process being investigated. For identification of the genes controlling cell proliferation, growth and viability in human lung adenocarcinoma cells (A549 cells), the WST-1 Cell Proliferation Assay was chosen as appropriate readout. A colorimetric assay, this semi-quantitative test estimates mitochondrial metabolic activity, thus giving an indirect indication of the number of live cells in a sample relative to an appropriate control population. In parallel, using separate aliquots from the same cultures, cell death was evaluated by a Lactate Dehydrogenase (LDH) release colorimetric assay, which measures the relative proportion of dead cells by quantifying the release of LDH enzymes into the cell culture supernatants upon cell membrane rupture (i.e., cell death).
For the technical details of genome-wide screen of A549 cells (Primary genome-wide screen, Candidate genes selection, Secondary (confirmation) screen and Hit genes selection), see Materials and Methods. Briefly, biostatistics analysis of the screening data identified 203 genes, mostly influencing A549 cell growth. As expected, well-characterized regulators of mitosis and cytokinesis (KIF11, PLK1, CDC2L1-2, E2F1) were identified as top hits, highlighting the reliability of the screen. There was also a characteristic pattern of RNAi screens with a high hit number involved in general gene expression (POLR2 subunits, elongation initiation factors, ribosomal subunits, spliceosome components). 16% of the total identified genes were not yet functionally annotated, and 12% of the siRNAs targeted predicted genes, i.e., genes that correspond to open reading frames (ORFs) from a database and are not yet confirmed as real genes.
Specific
Network construction and analysis of its specificity 2.2.1. General strategy for Specific Network construction Generally speaking, a Specific Network for a biological system may be defined as a network built on the hit genes selected in the genome-wide screen performed for this system, and proved to be significantly different from a random network built using the same random number of genes and the same rules for network construction. In reality, depending upon the chosen readout for a given genome-wide screen, its Specific Network does not reflect the whole biological system, but more precisely, the particular process investigated in this biological system (e.g., cell proliferation, differentiation, oxidative stress, etc.). Here, we addressed the question of growth control in A549 human lung adenocarcinoma cells, and used a cell proliferation/viability assay as readout; thus in our case we will construct a Specific A549 Growth Control Network.
Another important remark is that a Specific Network for a given biological system explicitly depends on the global ineraction databases(s) used for its construction (e.g., protein-protein interaction database(s), protein-gene interaction database(s), metabolic database(s), etc.). Of course, the best results for Specific Network construction will be obtained by using the "merger" of proteinprotein interaction, protein-gene interaction and metabolic databases. However, using only one global database for specific network constraction may be enough for addressing some important questions about particular molecular mechanisms. For example, for investigation of the signalling pathways underlying cell growth control in lung cancer, it is reasonable to construct a Specific Network using only protein-protein interaction (PPI) database(s), as most of these pathways consists of protein-protein interactions. Of course, information about other types of regulation will not be included in such an analysis, yet the results obtained with such a Specific Network can still be considered to be important ones, as long as the specificity (non randomness) of the network is well proven. To be accurate on this point, the Specific Network should be called, for example, the "A549 Specific PPI Network", if only protein-protein interaction database(s) were used for its construction.
Thus, strictly speaking, the "A549 Specific Network" that we analyse in this study and use as an example of an application of several new system biology tools for network analysis, should have the "full name" of "Specific PPI Network for Growth Control of A549 human lung adenocarcinoma cells".
We suggest the following rules for constructing a Specific Network using the results of a genome-wide screen:
1. The Network should be built on the hit genes (set of genes found in the genome-wide screen and statistically proven to be the most significant for the effect considered), using global ineraction databases (e.g., protein-protein interaction database(s), protein-gene interaction database(s), metabolic database(s), etc.). Normally, the proportion of hit genes should be around 1-5% of all the genes tested in the genome-wide screen.
2. If the connectivity of the obtained network, which we call the "Direct Network" (DN), is sufficient, the DN can be used as a Specific Network for further analysis. We may suggest that the criteria should be the size (in nodes) of the maximal connected component in the network, and this size for accepting the Direct Network as a Specific Network should be not less than 50% of the total number of genes in the hit list, proven to be statistically significant in this system; the best situation for accepting the Direct Network as a Specific Network is when the size of the maximal connected component is equal to or greater than 66-75% of the total number of genes in the hit list.
3. If the size of the maximal connected component of a Direct Network is smaller then 50% the number of hit genes, then the Specific Network should be built using hit genes together with Connectors (Network with Connectors, NC). This means that one should add to the nodes corresponding to hit genes all their first neighbors (FN) from an interaction database (FN are nodes with a 1-node distance from a given gene), and then choose for the Specific Network only those among the FN of the hit genes that each have more than one hit gene as their own FN (connectors). The advanced tool for construction of a "Network with Connectors" is BiNoM software [19] .
4. In the case where the Direct Network has a size (in number of nodes) around 50% of the hit list, or if it is composed of several medium-size connected components (=subnetworks) that are not connected between each other (i.e., not producing the common network), the following strategy seems to be the best: to built the Network with Connectors, then check the specificity of both networks (Direct Network and Network with Connectors), and choose as Specific Network the one which has more specificity according to the tests.
In all cases the specificity of the obtained network must be checked.
Analysis of network specificity
We suggest here two ways for checking the specificity of the obtained network: a) by evaluating the global compactness of the network and comparing it with that obtained for networks built on sets of randomly chosen genes; b) by comparing its degree of connectivity with that of networks built on sets of randomly chosen genes.
a) Global compactness of the network (Specificity as average internode distance)
We choose a given list of genes for creating the Specific Network, and characterize their distribution in the global PPI network by a single number:
where dist is the number of edges in the shortest path connecting hit i and hit j in the global network and N genes is the number of genes in the list. This can be called the global compactness measure G.
b) Degree of connectivity of a network (Specificity by Connectivity test)
Another test of non-randomness, inspired by percolation theory, can be proposed. On the figures showing the extracted networks, one can see that these networks contain a number of connected components of a certain size. It is important to estimate the probability of obtaining such connected components by chance.
Including information on protein complexes
Discussing the general strategy of analysis of network specificity, it is necessary to note that information on existing protein complexes is of the utmost importance for evaluation the specificity of the given network in comparison with the network built on a randomly chosen gene set. In other words, we would like to distinguish between those connections between proteins in the network belonging to well-known protein complexes, on the one hand, and those which were not previously investigated, on the other. This is especially important for the LOF screen data analysis, where the presence of the main housekeeping complexes is expected (e.g., elongation initiation complex, complex of ribosomal subunits, etc.), and thus high level of connectivity inside these complexes must not influence the evaluation of network specificity.
Two different approaches may be used to include the information about complexes ( Figure 1 ): 1) representation of protein complexes as separate nodes, and 2) representation of protein complexes as clicks; and the final result of network specificity evaluation can be strongly influenced by this choice. Next we will illustrate the application of the two specificity tests to the Direct A459 Network and compare the specificity results obtained for this network when one or the other of the abovementioned strategies for adding information about protein complexes is applied.
Analysis of A549 network specificity
The A549 Growth Control Network was created on 203 hit genes found in our genome-wide proliferation/viability LOF screen, using information on Protein-Protein Interaction (PPI) from the Human Protein Reference Database (HPRD, http://www.hprd.org) and visualizing it by Cytoscape Software [22] . In the network constructed using the Protein-Protein Interaction Database, all nodes represent proteins produced from the corresponding genes, and edges represent interactions between these proteins. The Direct PPI A549 Network contains only 134 hits out of the 203 used to create the network, due to the fact that predicted genes (ORFs) and non-characterized genes are not included in the HPRD database ( Figure 2 ). 
) Global compactness of the A459 Direct Network
We will calculate the p-value of the global compactness measure G for the A549 Direct Network in several ways (Table 1): 1) we take 10,000 randomly sampled sets of 134 hits (purely random); 2) we take 10,000 randomly sampled sets of 134 hits but such that each set has nodes with the same number of neighbors as in the hit set (conserving connectivity); in the case of the network where complexes are represented as nodes, the random nodes are chosen from 'non-complex' nodes.
3) we take 10,000 randomly sampled sets of 134 hits. We sample complexes presented in the hit set accordingly to the following rule: for each complex present in the initial hit list with k components (where k should be greater than or equal to M, the complex representation threshold), one randomly adds k components of the same complex to the sampling. Those proteins that do not belong to the represented complexes are sampled from the global network, with preservation of connectivity (as in case 2 above). Thus, each sampling generates 134 hits such that all complexes represented in the hit list are also represented by the same number of complex members in the sampling. Changing M, one can take into account only the most represented complexes, or else all complexes present in the hit list (conserving connectivity and complexes).
Analysis of the results in Table 1 leads to the following conclusions:
1) The distribution of hits is significantly more compact than random in the network where inside-complex interactions are represented as clicks. This significance remains valid for the purely random choice of nodes, for the choice conserving the connectivity distribution and for the sampling choice conserving representation of complexes represented in the initial hit list.
2) This compactness is explained mostly by inside-complex interactions, since, after removal of these interactions, the results become border-line (p-value = 0.1) if one conserves the connectivity distribution, and completely non-significant if one conserves the representation of complexes that are represented in the initial hit list. An additional methodological conclusion is that the representation of complexes as nodes, while useful for visualization, does not allow us to make conclusions about compactness (the results are not significantly different from random sampling when preserving at least the connectivity distribution).
Network without complexes
b
) Degree of connectivity of the A549 Direct Network
We will estimate the probability of obtaining such connected components as we obtained in the A549 Direct Network (Figure 2 ) by chance. We implement this idea using the same networks and sampling strategies as for the previous test. The results are presented in Table 2 . We can see that the appearance of a big connected component, of size 28 in the network with complex information included, is significant only if we use sampling preserving the connectivity, but is expected to happen if we also consider the representation of (at least the largest) complexes.The other connected component, of size 7, can be arrived at by chance with the sampling conserving the connectivity.
Thus, the main conclusion from the analysis of specificity of the Direct Network by the connectivity test is that we cannot consider this network to be specific.
Specificity of the A549 Network with Connectors (NC)
As the connectivity of the A549 Direct Network appears to be very small (the size of the maximal connected component is 8 out of a possible 134 nodes), then according to the rules we have proposed for Specific Network construction, the Specific Network for A549 lung adenocarcinoma cells should be built on the hit genes together with connectors ( Figure 5 ). In this case, 103 of the 134 nodes in the HPRD-curated hit list are present in the maximal connected component, which now consists of 245 nodes in total. This gives 50.7% of hit genes involvement in the network (77.4% of the HPRD-curated hit list), and if we prove that this network is specific, we will be able to derive meaningful conclusions from its analysis.
It is very important to note that, according to its definition, the specificity measured as average internode distance (G) is applicable to the list of genes (hit list in our case), and thus it will be the same for both the Direct Network and for the Network with Connectors that are built using the same hit list. And, as we already showed, this specificity is well proven (for the network with complexes as clicks, with conserving connectivity, and considering all complexes, the p-value for G is less than 0.1).
The evaluation of A549 NC specificity by the Degree of connectivity test also shows statistically significant results: the probability of obtaining 103 of the 134 random nodes in one connected component, by applying the strategy with connectors, using conserving connectivity, and considering all complexes, is around 0.05 (Table 3 ). This means that the A549 Specific Network, built as a Network with Connectors on the hit genes of our genome-wide screen using the HPRD database, is indeed found to be specific by both specificity tests.
Analysis of A549 Specific Network 2.3.1. Defining the most important nodes in the A549 LOF Specific Network
There are two main parameters which determine the relative importance of a node in the graph/ network: its connectivity and its centrality (betweenness) in the given network. Table 2 : Expected number of connected components of certain sizes in the extracted networks (only direct connections -inside-complex or others -are considered). In the first row, the records X:Y show the distribution of connected components' sizes, X=size of the connected component, Y=number of connected components of size X. In the rows beneath, X:Y means Y=number of connected components of size X or larger. The p-value is estimated for the appearance of Y connected components of size X or bigger (for example, for appearance of one large connected component of size 28 or more, which is the case for the hit list). The connectivity of a node is determined by its number of connections (edges) with its first neighbors, and the nodes with the highest level of connectivity (named hubs) are thought to be of the most importance for the given system.
Betweenness is one of the most frequently used measures of the centrality of a node within a network, showing the significance of a node for the pathways within a network.
Namely, nodes with higher levels of betweenness occur on more shortest pathways between other nodes in the network, than those that have lower levels of betweenness:
where B(n) is the betweenness of the node n, P ab is the number of shortest paths from node a to node b, and P ab (n) is the number of shortest paths from a to b that pass through a node n.
The connectivity and betweenness of all 245 genes (proteins) in the A549 Specific Network (including hit genes and connectors) was analysed (Table 4 ). This analysis identified several proteins (equivalent to the corresponding genes) with very high levels of connectivity in the given network, i.e., equal to or greater than 10 ( Table 4 , first column). However, it is also very important to know the level of connectivity for the given protein in the HPRD global network, and then to evaluate the ratio of the connectivity of a protein within the given network to its connectivity in the HPRD global network (Table 4 , second and third columns). This ratio is an especially important criterion in the case of proteins with a high level of global connectivity, because these proteins may use only a small percentage of their connectivity potential within the given network, while still having very high level of "absolute connectivity". The fourth column presents the value of betweenness for each protein.
From this analysis we may derive the following main conclusions about the most important genes in this system:
1. There are several genes (proteins) with significantly high levels of connectivity (> 10) in the Specific Network (two times or more greater than the average connectivity of a node in the global HPRD Network). Besides the expected pivotal proteins in cell proliferation and cell survival (such as TP53, RB1, SMAD2, JUN, E2F1, CDC2, EGFR, POLR2A, CASP3, spliceosome components (SNRPs), casein kinase, histones deacetylases, protein kinase C), and those already mentioned to be important in lung cancers (EGFR, HMGA1, GRB2), there are some that are less obvious, the presence of which in the list of hubs may point to the importance of these genes in A549 cells. The list of these genes includes well-known cancer genes that have not previously been shown to be important for lung cancer: BRCA1, CREBBP, SRC, MDM2, CRK and other proteins from different functional groups, NDRG1, PML, PAKI, SP1, PIN1, KPNB1, HTATIP, ABL1, SHC1, SMN1, FYN, DDX20, YWHAG, DHX9, CTNNB1, HSP90AA1. The three proteins from this list bearing the highest levels of connectivity are TP53, CREBBP, and CSNK2A1 (connectivity values of 38, 26, and 25, respectively).
2. Proteins that show the highest values for the ratio of connectivity-in-the-specific-network to connectivity-in-the-HPRD-global-network and also have a connectivity in the specific network greater or equal to 4 belong mostly to housekeeping-protein complexes: EIF3S8, EIF3S4, EIF3S9 -proteins of the elongation initiation complex RPL5, RPL6,RPS7 -ribosomal subunit proteins Table 4 : Connectivity and Betweennes of proteins in the A549 Specific Network (continuation) SNRPD3, SNRPD2, SNRPF, SNRPE, SNRPG -spliceosome components GEMIN6, GEMIN7, GEMIN5 -GEM-associated proteins (GEM is a GTP-binding protein). But there are also some proteins in the list that are not associated with protein complexes : STXBP3, SON, SF3A3, DHPS,  COPB2, WDR77, DDX20, SMN2, IK, GRAP, IL2RA, SIP1, HMGA1. 3. The third, and possibly, the best value to assign to a protein in the Specific Network for evaluating its significance by connectivity level would be the weighted connectivity (WC), which is the number of edges for the given protein in the network, weighted by its ratio to connectivity in the corresponding global network. Table 5 , first column, represents proteins from the A549 Specific Network with the highest score (equal or more than 5) of weighted connectivity. We can see that proteins of the spliceosome complex, ribonucleoproteins (GEMIN), as well as SMN proteins are found to be pivotal in the given Specific Network. There are two proteins whose highest level of significance for the given Specific Network can be elucidated only by checking their weighted connectivity score: STXBP3 and SIP1 (marked in red in the Table) .
4. Table 5 , second column, shows the most important proteins according to their betweenness, and finally, the third column represents those genes which are the most important for the A549 Specific Network by both weighted connectivity and betweenness. Figure 6a shows the distribution of values of betweenness for proteins in the A549 Specific Network; the threshold for considerably high values corresponds to the inflection of the curve.
5. According to the evaluation of the importance of a protein by two parameters, B and WC, ( Table 5 , third column), RPL5 has an extremely high level of significance, definitely unexplainable by its main known function (ribosomal subunit protein). Finally, we can see that the importance of two proteins in the A549 proliferation/viability Specific Network -RPL5 (apart from all other RPL and RPS proteins) and KPNB1 -was suggested by all three approaches considered in Table 5 . Moreover, on the plot showing the distribution of values of betweenness together with the ratio of connectivity in the A549 Specific Network (Figure 6b) , RPL5 protein appears to be the most significant one, whereas KPNB1 is the second in Additional information known about the RPL5 protein is that it specifically interacts with the beta subunit of casein kinase II [25] . Interestingly, it was shown that, in colorectal cancers, expression of the RPL5 gene in tumour tissue differs from that in adjacent normal tissues [24] . KPNB1 protein is a member of the importin beta family, involved in nuclear-cytoplasmic transport [23] . Thus, the significance of these two proteins for a lung cancer cell line is a completely unexpected result which may be of considerable importance.
In addition to these two proteins, our bioinformatics analysis suggests that CSNK2A1, SNRPD2, NDRG1, CREBBP, DHX9, and IL16 proteins may be the most important ones for A549 cell growth/viability. It is important to mention that IL16 was found to be very significant by the two-parameters test, although it was not identified by any of the single parameter tests.
Creating subnetworks specific to individual biological processes in the system
As a first step, simple mathematical modeling, was undertaken to elucidate the interplay between proliferation and viability processes in the phenotypical effect of knocking down each individual gene.
According to the method applied for reading the screening data, the effect of an siRNA-induced knockdown of mRNA expression for a given gene is quantified 3 days post siRNA treatment, by simultaneous measurement of (1) the final quantity of cells in the corresponding samples and (2) the release into the supernatant of a cytoplasmic enzyme by dying/dead cells. This final effect of the siRNAs on cell quantities could essentially be due to cell cycle arrest, cell death, or to various combinations of these two processes. Additionally, both of these processes could occur with different kinetics over the time-course of the experiment (for example, a late cell death combined with an early proliferation inhibition).
To elucidate the process in which the significant genes and pathways we found are mainly involved, namely to discriminate between their influence on cell proliferation and cell survival, a mathematical modeling, taking advantage of the availability of data about these two processes, was performed and next applied to the results of our proliferation and toxicity assays (see Material and Methods sections for experimental details).
As a result, we have obtained a list of genes with significant effects on cell survival and a list of genes with significant effects on proliferation, which allow us to retrieve the corresponding Proliferation and Cell survival subnetworks from the A549 Specific Network. a) Mathematical model For creating the simple mathematical model, we assume that the quantity of cells growing in the culture increases at a normal rate of proliferation in the normal (control) case, and increases at an unknown rate of proliferation and decreases by cell death in the experimental case.
Thus for live cells we can write:
for dead cells:
where a is the amount of alive cells, b is the amount of dead cells, p is the coefficient of proliferation, and µ is the coefficient of cytotoxicity (cell death).
The solution for a will be:
Let a c be the final amount of live cells in the control, a 0 is the initial amount of cells in the tube (well), then
where p c is the rate of proliferation in control case, coefficient 8 came from the experimental data for the control case; we will consider t = 1, as the end of experiment is the first point of measurement.
Two biological measurements, namely, NPI (Normalized Percent of Inhibition) as the result of proliferation screen, and T (percent of dead cells) as the result of toxicity screen, were made at the end of the experiment for each tube, corresponding to each gene.
By definition:
where a f is the final amount of live cells and b f is the final amount of dead cells for the siRNA sample being considered.
From initial system of equations we have for T :
Next we get:
Now we would like to find all cases in corresponding to the condition p c − p > µ which means that the decrease in proliferation rate due to knockdown of the given gene is greater than the decrease which occurs due to the toxicity effect of its knockdown:
From (2.11) we have p − p c = ln(1 − N P I) + µ, thus, our condition for such cases will be:
Now from (2.6) and (2.8) we can derive an expression µ = T (2 + ln(1 − N P I)) 7 8 − N P I from which we have our final criteria to distinguish those cases in which the decrease in proliferation rate due to knockdown of a gene is greater than the decrease which occurs due to the toxicity effect of its knockdown, based on the two corresponding experimental values N P I and T :
. Next, this criteria was applied to the NPI and T results obtained for A549 human lung adenocarcinoma cell line genes. As the experiments for all of the individual siRNAs were done in triplicate, both NPI and T values were included in (8), together with their standard deviations.
As a result of the analysis, the following values were assigned to the corresponding pair of T /N P I data for each siRNA:
"1"-if the total decrease in final cell quantity is due rather to a decrease in proliferation rate than to cell death because of cytotoxicity, "2"-if both effects are equal for the given siRNA treatment. "3"-if the total decrease in final cell quantity is due rather to the influence of the toxicity effect than to proliferation-rate slowing or cell-cycle arrest.
Finally, after summarizing results obtained for the 4 siRNAs tested per gene, we got values allowing us to distribute genes of interest into the three groups described above. Table 6 illustrates this technique applied to the list of hit genes of the A549 screen.
Next, it is possible, by applying thresholds defined from the details of the experiment/assay, to discriminate specific groups of genes of interest. For example, calculating the thresholds from reciprocal results of the controls in both assays and taking into consideration their standard deviations, it was possible to determine the specific groups of genes whose knockdown effect on cells is "toxic only" and "arrest of proliferation only", and to identify specific cases such as "overproliferation" (Table 7) . Overproliferation means that knockdown of a gene results in more active proliferation than in normal cells (NPI is less than zero). If needed, these genes can be easily included in the mathematical model as an additional group. But for the A549 screen, where this case was excluded from the selection of hits, it is still important to note that for the cases where a considerable cytotoxic effect of the siRNA is coupled with no or a very small effect on NPI, we also have a case of overproliferation -as defined above -which compensates the loss of cells due to toxicity. Elucidation of these specific groups, and especially of the group of genes the knockdown of which causes proliferation arrest without affecting cell death is extremely important for possible cancer therapies. ABCA2  ABAT  ADAM10  GRAP  RPS10  ABCF1  ABCC2  ADAMTS12  GUCA2A  RPS13  ACTN4  ABCG1  ANTXR1  HAS2  RPS14  AMPD3  ADCY5  AQR  HMGA1  RPS18  DKFZp434G0625  ALDH3B2  ARCN1  IGF2R  RPS20  DKFZp434P0216  C18orf25  ARHGEF4  KCNQ1DN  RPS21  DPH2L1  CA11  ASGR1  KCNQ2  RPS24  E2F1  CCR7  BSCL2  LCE1E  RPS25  GPX4  CEBPA  TMCO3  MGC27169  RPS3A  GRHPR  COPB2  C2orf28  MGC3196  RPS4X  HOM-TES-103  CTRC  CASK  MGRN1  RPS5  IGSF1  DHPS  CCT5  MGST3  RPS6  IK  DLX3  CDC2L1  MRPS24  RPS8  KIF11  DNASE1  CDC2L2  NFE2L2  RPS9  KPNB1  DSCAM  CDRT15  NMT1  SART1  MGC35521  FLJ20643  ch-TOG  NRM  SCNN1A  NXF1  FLJ46354  COPA  NUT  SELV  OR51G1  GPR133  COPB  OR2AT4  SF3A3  OR52H1  HIST1H2BA  CP  OR7A5  SF3B14  OR52N2  IL16  CPA5  PACS1  SMNDC1  PLK1  IL2RA  CRK  PB1  SMU1  POLA  KCNV1  DDX23  PDE6G  SNRPF  RRP22  KLF6  DKFZp564I1922 PEPD  SOAT2  SNRPD3  MIA  DLST  PES1  SON  TREH  MST1  EIF3S10  PEX16  SUPT6H  TRPV6  NRXN2  EIF3S4  PEX5  TALDO1  XAB2  P2RY12  EIF3S5  RBM25  TKT  PCF11  EIF3S6  RPL10A  TRIM21  POLR2A  EIF3S8  RPL11  UACA  PRPF8  EIF3S9  RPL12  UBA52  RPAP1  ELYS  RPL19  VprBP  RPS7  ET  RPL21  VWF  SC65  FAM50A  RPL24  WIPI-2  SEC61A1  FAU  RPL3  XRCC2  SF1  FLJ13052  RPL30  SF3B1  FLJ20280  RPL35  SIN3A  FLJ20516  RPL36  SIT  FLJ44076  RPL5  SLC16A13  GA17  RPL7  SLC22A14  GABRD  RPL7A  SNRPD2  GD:PTPRD  RPL8  SUV420H2  GJE1  RPL9  USP11 GPR132 RPLP1 DKFZp434P0216 RPL19  EIF3S6  ARCN1  HIST1H2BA  NXF1  RPL11  EIF3S4  ANTXR1 SC65  TRPV6  RPL21  EIF3S8  ASGR1  AMPD3  RPL24  EIF3S9  BSCL2  RPL3  ET  C2orf28  RPL30  FLJ13052  CDC2L2  RPL35  GD:PTPRD CP  RPL36  GJE1  SCNN1A  RPL5  KCNQ2  SELV  RPL7  MGC27169 SUPT6H  RPL7A MGRN1  TALDO1  RPL8  NFE2L2  UBA52  RPL9  NMT1  VWF  RPLP1  NRM  RPS10  NUT  RPS3A PACS1  RPS5  PB1  RPS9  PEX16   Table 7 : Special group of genes: genes controlling only one cell process (cell survival or cell proliferation) and genes having toxic and overproliferation effects.
Following this analysis, it is of particular interest to notice the striking difference between three housekeeping complexes, obviously important for cell growth, namely: elongation initiation factors, ribosomal subunits, and spliceosome components. According to the mathematical modelling, the knockdown of all elongation initiation factors and all ribosomal subunits has exclusively affects proliferation arrest, whereas knockdown of spliceosome components also has partially or completely toxic effects. b) Extraction of Proliferation and Cell Survival Subnetworks from A549 Specific Network Next, based on the results of our mathematical modeling, Proliferation and Cell Survival subnetworks were derived from the A549 Specific Network (Figure 7 and Figure 8 ). This allows us to identify some of the specific pathways important for proliferation or for cell survival in our system. For subnetwork extraction, all genes from the Specific Network were analyzed using our mathematical model, and the specific processes affected by each of them were determined. Then, for the Proliferation Subnetwork, all genes with proliferation arrest and equal effect were extracted, and, correspondingly, for the Cell Survival Subnetwork, all genes with cell death and equal effects were extracted. Figure 10a (Cell Survival module 1) shows that the suppression of members of the spliceosome complex is much more crucial for A549 cell survival, than it is for their proliferation activity. Cell Survival module 2 (Figure 10b) , which includes hit genes ADCY5, TRPV6, DLX3(B) and three small putative cell-survival pathways (Figure 10c ) presents an opportunity to discover new pathways important for A549 viability and survival. Figure 11 helps to elucidate the possible role of RPL5 in the A549 Specific Network, showing that it is an important hub in this system, located on the intersection of proliferation pathways (RPL and RPS proteins), cell survival pathways (SMNDC1, KPNB1 proteins), and, via casein kinase II, pathways involved in the regulation of cancerogenesis.
Discussion
In this work, we suggest several analytical tools for systems biology analysis of the results of genome-wide loss-of-function screens. First of all, we introduce the definition of Specific Network for the given system, and propose the rules for its construction based on the list of hit genes identified in the course of a genome-wide LOF screen. Second, we worked out two different strategies for checking the specificity of the created network, which allows us to state that the initial hit list and Specific Networks driven from our analysis are relevant to the investigated biological system. Including information on protein complexes in the evaluation of network specificity is a crucial element for a genome-wide LOF screen network analysis, because the presence of housekeeping complexes, such as ribosomal subunit complexes, spliceosome complexes, etc., must not bias the network specificity results. Next, we present our mathematical model allowing the discrimination between two processes that may result simultaneously from the knockdown of a given gene. Namely, in the example discussed above, where the readout of the screen quantifies the final amount of cells after gene knockdown, the mathematical model we suggest permits discrimination between its effect on cell proliferation versus effect on cell survival processes. At the network level, this discrimination also allows the creation of corresponding subnetworks from the Specific Network, which in turn, opens avenues for elucidating pathways important for each of these processes in the system. All the systems biology methods reported in this paper were illustrated by application to the results of a genome-wide LOF screen of A549 human lung adenocarcinoma cell proliferation/viability. The analysis of the A549 proliferation/viability Specific Network revealed 29 most important genes (hubs) and several important pathways and modules relevant to human lung adenocarcinoma proliferation activity and/or cell viability in this system. Understanding the involvement of these genes and pathways in cell proliferation or in cell survival/maintenance could be particularly useful to orientate follow-up research on the given biological system, based on the importance of the identified subnetworks and their derived pathways. Genes from pathways found to be preferentially involved in cancer cell survival would be expected to be more relevant targets for further cancer therapy research than genes involved in cancer cell proliferation processes. Eventually, that hypothesis should be tested both from bioinformatics (by comparison of the relative importance of proliferation and survival subnetworks obtained from LOF screens in cancer cells and their non-tumoral counterparts) and experimental points of view.
Some of the results of our analysis of the A549 Specific Network are summarized below: -some genes known to be involved in cancer progression, but not previously identified as being the most significant ones in lung adenocarcinoma, showed up as being highly important for this system, because they had the highest levels of connectivity and centrality (betweenness) in the A549 proliferation/viability Specific Network (BRCA1, CREBBP, SRC, MDM2, CRK); -some new genes previously not linked to cancer progression, were found to be extremely important for A549 cell growth: RPL5, KPNB1, SNRPD2, DHPS, CSNK2A1,SNRPD2, NDRG1, CREBBP, DHX9 , IL16.
-several new pathways important for A549 cell proliferation, and several new pathways important for A549 cell survival were also suggested.
Statistically, the most pivotal genes/proteins obtained in the analysis are RPL5 and KPNB1 proteins. The importance of RPL5, apart from all other RPL and RPS proteins, was suggested by all the approaches we used in network analysis. Definitely, the extremely high rank of RPL5 significance for the A549 network cannot be explained by its main known function (ribosomal subunit protein) in the translational process, suggesting possibile additional specific functions of this protein in lung adenocarcinoma cells. It was shown that, in colorectal cancers, expression of RPL5 in tumours differs from that seen in adjacent normal tissues [24] , and that RPL5 specifically interacts with the beta subunit of casein kinase II [25] . One possible explanation of RPL5's importance may be obtained from pathway analysis, showing that RPL5 is a hub on the intersection of proliferation (RPL and RPS proteins) and cell survival pathways (SMNDC1, KPNB1 proteins).
KPNB1 protein is a member of the importin beta family, involved in nuclear-cytoplasmic transport [23] . Mathematical modeling shows that its knockdown results mainly in cell death rather than in proliferation arrest, thus elucidating the importance of this protein for maintaining A549 viability. The significance of these two proteins for lung cancer cells was not previously shown, and thus may be of considerable importance.
Analysis of proliferation and cell-survival subnetworks highlights the striking difference in this biological system between three housekeeping complexes that are obviously important for cell growth, namely: elongation initiation factors, ribosomal subunits, and spliceosome components. Whereas elongation initiation and ribosomal subunits complexes belong to a proliferation subnetwork, the spliceosome complex belongs to a cell death subnetwork, indicating its high importance for cell survival.
Another interesting fact is that the analysis of the A549 Specific Network pinpointed the spliceosome component SNRPD2 as one the most important proteins in this system, though no information about its possible connection with cancer progression currently exists. Interestingly, there is some cancer-related data in the HPRD database for other members of SNRPD family, especially SNRPD3, including one in lung cancer (J. of Proteome research).
In conclusion, this study outlines a systems biology strategy for the identification of genes and pathways that are important for a given biological system. The approach we suggest opens up new perspectives for the most important goal of such genome-wide techniques -i.e., suggestions for researching possible novel therapeutic targets -because it helps to determine the most important genes in the given biological system, which may be different from the most active genes in the list of hits identified by a genome-wide LOF screen. Additionally, this approach helps to bring to light other important genes of the system, which may potentially be found in the analysis of the corresponding Specific Network even if they were missed during the LOF screen for technical or procedural reasons. Consequently, we suggest that further biological analyses should be performed on those genes identified in our study as being very important ones, but that until now have not been functionally associated with oncogenesis and/or with development of human lung adenocarcinoma.
Materials and Methods
The A549 human lung adenocarcinoma cell line was provided by G. Kroemer, INSERM U848, Institut Gustave Roussy, Villejuif, France. The A549 cell proliferation and viability genome-wide screen was conducted in 96-well tissue culture plates, using a library assembled with individual synthetic siRNAs of predicted sequences targeting the whole human genome (22,950 targeted genes, 2 different siRNAs per gene, Qiagen). With the aid of automation (8-channel Star, Hamilton), siRNAs targeting each human gene and the control siRNAs were individually transfected in triplicate into A549 cells using Hiperfect (Qiagen); 72 hours after transfection, a toxicity assay and a proliferation/viability assay were performed in parallel on separate aliquots from each well. For the toxicity assay, an aliquot of supernatant from each well was used for quantification of lactate dehydrogenase (LDH), which is released by dead or dying cells (LDH Cytotoxicity Assay, Roche). Next, the remainder of the material from the well was tested for cell proliferation/viability using the WST-1 assay (Roche).
Candidate gene selection: Raw data were rescaled according to control-based (Normalized Percentage of Inhibition, NPI) and sample-based normalizations (robust Z-Score, B-score), and, when needed, corrected for positional effects using the sample well correction method (Kevorkov et al. 2005) . A siRNA was defined as being active when its normalized value deviated by more than 3*MAD from the sample siRNAs median in at least one of the normalization procedures. The candidate list was constructed with genes for which at least one siRNA was defined as active.
Secondary screen: The candidate genes were then reassayed for proliferation and cytotoxicity in a confirmatory screen identical to the Primary screen but with 4 siRNAs tested per gene (the 2 that were previously tested + 2 additional siRNAs). To select the hit genes, the balanced activity of each set of 4 siRNAs/gene on cell proliferation was computed as a single score. An arbitrary threshold, corresponding to the score of 4 siRNAs with a theoritical activity of 20% inhibition of A549 cell growth, was set as hit selection threshold.
For the selection of Candidate and Hit Genes, mostly influencing A549 cell growth, biostatistics analysis of screen datasets was performed under the R environment with Bioconductor packages.
